Edgewise Therapeutics Investors

21 investors on Angel Roster list Edgewise Therapeutics in their portfolio. Most are venture capital firms and private equity firms, the most common stage is Series A and the largest groups are based in the United States, Israel and China.

Investors are matched on the company name in their portfolio, so companies that share the name Edgewise Therapeutics can appear together.

Investors listed
21
With verified email
43%
Most common stage
Series A
Top location
United States

Updated October 13, 2026 · How we compile this data

Top 21 Edgewise Therapeutics investors

The most complete profiles first. Showing 21 of 21.

  • David BonitaVerified

    Venture Capital, Private Equity Firm, Investor · United States

    SeedSeries AHealth CareInvestment ManagementLife ScienceInformation Technology (IT)

    Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 93 more

    Verified email available

  • Geoffrey HsuVerified

    Venture Capital, Private Equity Firm, Investor · United States

    SeedSeries AHealth CareInvestment ManagementLife ScienceInformation Technology (IT)

    Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more

    Verified email available

  • Jon RootVerified

    Venture Capital · United States

    Health CareCybersecurityWomen FoundedEnterprise Software

    Portfolio: Livefyre, Edgewise Therapeutics, HighLife, ZypMedia and 61 more

    Verified email available

  • Jonathan SilversteinVerified

    Private Equity Firm · United States

    Health CareLife ScienceInformation Technology (IT)Mobile

    Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more

    Verified email available

  • Jonathan WangVerified

    Private Equity Firm · China

    Health CareLife ScienceInformation Technology (IT)Mobile

    Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more

    Verified email available

  • Rick LewisVerified

    Venture Capital · United States

    Health CareCybersecurityWomen FoundedEnterprise Software

    Portfolio: Livefyre, Edgewise Therapeutics, HighLife, ZypMedia and 61 more

    Verified email available

  • Rishi GuptaVerified

    Private Equity Firm · United States

    Health CareInvestment ManagementLife ScienceInformation Technology (IT)

    Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more

    Verified email available

  • Ron HuntVerified

    Venture Capital, Private Equity Firm · United States

    Health CareCybersecurityMessagingWomen Founded

    Portfolio: iRhythm Technologies, Braeburn, Direct Flow Medical, Edgewise Therapeutics and 56 more

    Verified email available

  • Steve KrauszVerified

    Venture Capital · United States

    Health CareCybersecurityWomen FoundedEnterprise Software

    Portfolio: Livefyre, Edgewise Therapeutics, HighLife, ZypMedia and 66 more

    Verified email available

  • Carter Neild

    Venture Capital, Private Equity Firm, Investor · United States

    SeedSeries AHealth CareInvestment ManagementLife ScienceInformation Technology (IT)

    Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more

    Contact details available

  • Chau Khuong

    Venture Capital, Private Equity Firm, Investor · United States

    SeedSeries AHealth CareLife ScienceInformation Technology (IT)Mobile

    Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Gennao Bio, Yisheng Biopharma and 89 more

    Contact details available

  • Jacques Benkoski

    Venture Capital, Strategy Operator, CEO · United States

    Series AHealth CareCybersecurityWomen FoundedEnterprise Software

    Portfolio: Livefyre, Edgewise Therapeutics, HighLife, ZypMedia and 64 more

    Contact details available

  • Scotland Stevens

    Venture Capital, Private Equity Firm, Investor · United States

    SeedSeries AHealth CareInvestment ManagementLife ScienceInformation Technology (IT)

    Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more

    Contact details available

  • Anat Naschitz

    Private Equity Firm · Israel

    Health CareLife ScienceInformation Technology (IT)Mobile

    Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more

    Contact details available

  • Craig Slutzkin

    Venture Capital, Private Equity Firm · United States

    Health CareCybersecurityMessagingWomen Founded

    Portfolio: iRhythm Technologies, Braeburn, Direct Flow Medical, Edgewise Therapeutics and 56 more

    Contact details available

  • Dafina Toncheva

    Venture Capital · United States

    Health CareCybersecurityWomen FoundedEnterprise Software

    Portfolio: Livefyre, Edgewise Therapeutics, HighLife, ZypMedia and 64 more

    Contact details available

  • Erez Chimovits

    Private Equity Firm · Israel

    Health CareInvestment ManagementLife ScienceInformation Technology (IT)

    Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more

    Contact details available

  • James Niedel

    Venture Capital, Private Equity Firm · United States

    Health CareCybersecurityMessagingWomen Founded

    Portfolio: iRhythm Technologies, Braeburn, Direct Flow Medical, Edgewise Therapeutics and 56 more

    Contact details available

  • Jeffrey Ives

    Venture Capital · United States

    Health CareCybersecurityMessagingWomen Founded

    Portfolio: iRhythm Technologies, Braeburn, Direct Flow Medical, Edgewise Therapeutics and 56 more

    Contact details available

  • Rebecca Luse

    Venture Capital · United States

    Health CareCybersecurityMessagingWomen Founded

    Portfolio: iRhythm Technologies, Braeburn, Direct Flow Medical, Edgewise Therapeutics and 56 more

    Contact details available

  • Vijay Lathi

    Venture Capital, Private Equity Firm · United States

    Health CareCybersecurityMessagingWomen Founded

    Portfolio: iRhythm Technologies, Braeburn, Direct Flow Medical, Edgewise Therapeutics and 56 more

    Contact details available

Frequently asked questions

How many Edgewise Therapeutics investors are on Angel Roster?

Angel Roster lists 21 Edgewise Therapeutics investors. 9 of them (43%) include a verified email address.

What types of investors are they?

The most common investor types are Venture Capital Firms (16), Private Equity Firms (14) and Strategy Operator Investors (1). An investor can have more than one type, for example an angel who is also a venture partner.

Which stages do Edgewise Therapeutics investors invest in?

Among those that list a stage, the most common are Series A (6) and Seed (5).

Where are Edgewise Therapeutics investors based?

Most are based in the United States (18), Israel (2) and China (1).

Which companies have Edgewise Therapeutics investors backed?

The most-backed portfolio companies among them are Passage Bio (16), UNUM Therapeutics (16), ReViral (16), Silverback Therapeutics (15) and Cleave Therapeutics (15).

How do I contact Edgewise Therapeutics investors?

Create a free Angel Roster account to search and filter all 21, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.